The U.S. Food and Drug Administration has approved Tris Pharma's once-daily Onyda XR (clonidine hydrochloride) as the first liquid, nonstimulant treatment for attention-deficit/hyperactivity disorder (ADHD).
Jun 4, 2024
0
3
Attention deficit hyperactivity disorder (ADHD) is a common neurodevelopmental disorder characterized by elevated levels of inattention, impulsivity, and hyperactivity that can impair academic and social functioning. ADHD ...
Jun 4, 2024
0
0
A new study to be presented at the SLEEP 2024 annual meeting found that household chaos and sleep hygiene are important factors in the relationship between sleep quality and ADHD symptoms in teens.
May 31, 2024
0
0
Digital health experts at Flinders University are developing a mobile self-monitoring app model to assist adults with Attention-Deficit Hyperactivity Disorder (ADHD) take a more pro-active role in their "wellness journey."
May 30, 2024
0
0
Sweden is seeing "an explosion" of ADHD cases among children that has put it far above the global average, the government said Friday as it ordered a review to find out why.
May 24, 2024
0
0
New research has revealed the extensive impact of Attention Deficit Hyperactivity Disorder (ADHD) highlighting mental health vulnerabilities, physical health risks, and societal implications, emphasizing the need for a holistic ...
May 23, 2024
0
2
An exploration into the national U.S. dataset on children ever diagnosed with ADHD has revealed an "ongoing and ever-expanding" public health issue.
May 23, 2024
0
1
Cambridge scientists have shown that problems regulating emotions—which can manifest as depression, anxiety and explosive outbursts—may be a core symptom of attention deficit hyperactivity disorder (ADHD).
May 22, 2024
0
44
A study in the Journal of the American Academy of Child and Adolescent Psychiatry found that pharmacological treatment of attention-deficit/hyperactivity disorder (ADHD) reduced violence- and public-order related crimes. ...
May 14, 2024
0
0
The number of people accessing medication for attention-deficit hyperactivity disorder (ADHD) in Aotearoa New Zealand increased significantly between 2006 and 2022. But the disorder is still underdiagnosed and under-treated ...
May 3, 2024
0
0
